Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease

M Tsalenchuk, SM Gentleman, SJ Marzi - npj Parkinson's Disease, 2023 - nature.com
Sporadic Parkinson's disease (PD) is a progressive neurodegenerative disease, with a
complex risk structure thought to be influenced by interactions between genetic variants and …

N6-methyladenosine and neurological diseases

N Zhang, C Ding, Y Zuo, Y Peng, L Zuo - Molecular neurobiology, 2022 - Springer
Abstract N6-methyladenosine (m6A) is a dynamic reversible methylation modification of the
adenosine N6 position and is the most common chemical epigenetic modification among …

One-carbon metabolism: pulling the strings behind aging and neurodegeneration

E Lionaki, C Ploumi, N Tavernarakis - Cells, 2022 - mdpi.com
One-carbon metabolism (OCM) is a network of biochemical reactions delivering one-carbon
units to various biosynthetic pathways. The folate cycle and methionine cycle are the two key …

Parkinson's disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical …

J Kochmanski, NC Kuhn, AI Bernstein - npj Parkinson's Disease, 2022 - nature.com
Evidence for epigenetic regulation playing a role in Parkinson's disease (PD) is growing,
particularly for DNA methylation. Approximately 90% of PD cases are due to a complex …

Multifaceted collagen-DDR1 signaling in cancer

H Su, M Karin - Trends in cell biology, 2023 - cell.com
In addition to immune cells and fibroblasts, the tumor microenvironment (TME) comprises an
extracellular matrix (ECM) which contains collagens (COLs) whose architecture and …

DNA methylation as a mediator of genetic and environmental influences on Parkinson's disease susceptibility: Impacts of alpha-Synuclein, physical activity, and …

SL Schaffner, MS Kobor - Frontiers in genetics, 2022 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder with a complex etiology and
increasing prevalence worldwide. As PD is influenced by a combination of genetic and …

Immunological shifts during early-stage Parkinson's disease identified with DNA methylation data on longitudinally collected blood samples

SC Pike, M Havrda, F Gilli, Z Zhang, LA Salas - npj Parkinson's Disease, 2024 - nature.com
Parkinson's disease (PD) is the second most common neurodegenerative disease in the
United States. Decades before motor symptoms manifest, non-motor symptoms such as …

Epigenetic changes in prion and prion-like neurodegenerative diseases: Recent advances, potential as biomarkers, and future perspectives

A Hernaiz, JM Toivonen, R Bolea… - International journal of …, 2022 - mdpi.com
Prion diseases are transmissible spongiform encephalopathies (TSEs) caused by a
conformational conversion of the native cellular prion protein (PrPC) to an abnormal …

[PDF][PDF] Single Nucleotide Polymorphisms of Indoleamine 2, 3-Dioxygenase1 Influenced the Age Onset of Parkinson's Disease

N Török, R Maszlag-Török, K Molnár… - Frontiers in Bioscience …, 2022 - real.mtak.hu
Background: Earlier studies reported alterations of the kynurenine (KYN) pathway of
tryptophan (TRP) metabolism in Parkinson's disease (PD). The first rate-limiting enzymes …

Epigenetic modification in Parkinson's disease

H Song, J Chen, J Huang, P Sun, Y Liu, L Xu… - Frontiers in Cell and …, 2023 - frontiersin.org
Parkinson's disease (PD) is a common neurodegenerative disorder caused by genetic,
epigenetic, and environmental factors. Recent advance in genomics and epigenetics have …